Allopurinol fails to improve CV outcomes in ischemic heart disease patients: ALL-HEART trial Dr.Niharika Harsha B12 Oct 2022 8:30 PM ISTA recent study found that allopurinol did not improve the primary outcomes in cardiovascular patients aged 60 years or older with ischemic heart...
Allopurinol not tied to mortality risk in patients with gout with CKD, study finds Medical Dialogues Editorial Team4 Feb 2022 9:00 AM ISTChina: A new study shows that neither the commencement of allopurinol, the achievement of the target serum urate (SU) level with allopurinol, nor the...
Allopurinol non-inferior to febuxostat for gout treatment: Study Medha Baranwal3 Dec 2021 9:00 AM ISTUSA: Allopurinol, when dosed appropriately as part of a treat-to-target strategy, is non-inferior to febuxostat for gout treatment, according to...
Allopurinol may increase CV risk, mortality in gout compared to benzbromarone: Study MD Editorial Team26 Nov 2021 9:00 AM ISTSouth Korea: Results from a large population-based cohort showed that allopurinol is related to an increased risk of all-cause mortality and composite...
Early allopurinol initiation in acute gout flare has no significant benefit: Study MD Editorial Team11 Oct 2021 9:00 AM ISTGout is among the most prevalent etiologies of chronic inflammatory arthritis in the United States. The evaluation and management of gout and...
Urate lowering agents don't slow progression of CKD in hyperuricemia, finds study MD Editorial Team7 Oct 2021 10:12 PM ISTHyperuricemia is very common in CKD patients because of reduced urinary excretion of uric acid. The role of uric acid in the development CKD and...
Febuxostat has similar CV safety as Allopurinol when used in Gout: Study Dr. Shravani Dali19 July 2021 9:30 AM ISTFebuxostat used for Gout did not substantially increase the risk of cardiovascular events or death when compared to the usage of Allopurinol,...
Urate-lowering therapy with allopurinol does not lower systolic BP, Finds study Dr. Nandita Mohan25 Jun 2021 9:15 AM ISTAccording to a recent research, it has been observed that urate-lowering therapy with allopurinol does not lower systolic BP or hsCRP level in ...
Allopurinol fails to reduce kidney complications in type 1 diabetes: Study Dr. Kamal Kant Kohli30 Jun 2020 11:00 AM ISTScientists have found in PERL study that reducing levels of uric acid in the blood by using allopurinol does not guard against kidney complications...
Allopurinol does not prevent worsening of CKD finds clinical trial Dr. Kamal Kant Kohli25 Jun 2020 3:09 PM ISTAustralian and New Zealand researchers have found in a new study that a drug allopurinol used to slow chronic kidney disease in up to 20 per cent of...
Allopurinol is first line therapy for Gout, declare ACR Guidelines Dr. Kamal Kant Kohli14 May 2020 7:02 AM ISTAmerican College of Rheumatology has recommended Allopurinol as the first-line treatment for managing gout .According to updated guidelines from...
